Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study

CONCLUSION: Our data suggest that lower MCS at AS enrollment using patient-reported outcomes was negatively associated with the first repeat protocol biopsy compliance. Our study may support the availability of a simple questionnaire to extract non-compliance.PMID:34112576 | DOI:10.1016/j.urolonc.2021.05.003

Source: Urologic Oncology - June 11, 2021 Category: Urology & Nephrology Authors: Yoichiro Tohi Takuma Kato Akira Yokomizo Koji Mitsuzuka Ryotaro Tomida Junichi Inokuchi Ryuji Matsumoto Toshihiro Saito Hiroshi Sasaki Koji Inoue Hidefumi Kinoshita Hiroshi Fukuhara Satoru Maruyama Shinichi Sakamoto Toshiki Tanikawa Shin Egawa Haruhiko Ic Source Type: research